Warning

References

  1. FSRH Guidance (Feb 2021 updated July 2023 ) Progestogen Only Implants https://www.fsrh.org/Public/Documents/clinical-guidance-progestogen-only-implants.aspx [accessed 30/05/2024]
  2. FSRH Clinical Effectiveness Unit. UK Medical Eligibility Criteria for Contraceptive Use [Internet]. The Faculty of Sexual and Reproductive Healthcare; 2016 Apr [updated 2019 Sep] Available from: https://www.fsrh.org/Common/Uploaded%20files/documents/fsrh-ukmec-full-book-2019.pdf[accessed 30/05/2024] 
  3. FSRH Clinical Effectiveness Unit. FSRH Clinical Guideline: Problematic Bleeding with Hormonal Contraception [Internet]. The Faculty of Sexual and Reproductive Healthcare; 2015 https://www.fsrh.org/Public/Documents/ceu-guidance-problematic-bleeding-hormonal-contraception.aspx[accessed 30/05/2024] 
  4. FSRH Clinical Effectiveness Unit. FSRH Guidance: Drug Interactions with Hormonal Contraception [Internet]. The Faculty of Sexual and Reproductive Healthcare; 2022 May [cited 2022 March 14]. https://www.fsrh.org/Common/Uploaded%20files/documents/drug-interactions-with-hormonal-contraception-5may2022.pdf[accessed 30/05/2024] 
  5. CEU Statement: Management of women taking anticoagulants or antiplatelet medications who request intrauterine contraception or subdermal implants 29th March 2017 
  6. FSRH Clinical Guideline: Quick Starting Contraception (April
    2017) https://www.fsrh.org/Common/Uploaded%20files/documents/1fsrh-guideline-quick-starting-contraception-april-2017.pdf[accessed 30/05/2024] 

Editorial Information

Last reviewed: 31/05/2024

Next review date: 31/05/2026

Author(s): West of Scotland Managed Clinical Network for Sexual Health Clinical Guidelines Group .

Version: 9.1

Approved By: West of Scotland Managed Clinical Network for Sexual Health